Thrivent Financial For Lutherans Xencor Inc Transaction History

Thrivent Financial For Lutherans

$51.6 Billion
Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Xencor Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 122,897 shares of XNCR stock, worth $1.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

122,897

Previous 116,369 5.61%

Holding current value

$1.99 Million

Previous $2.34 Million 20.68%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$19.43 - $26.84 $126,839 - $175,211	6,528 Added 5.61%	122,897 $2.82 Million
Q3 2024 Nov 07, 2024	BUY	$15.7 - $21.65 $1.02 Million - $1.41 Million	65,180 Added 127.33%	116,369 $2.34 Million
Q2 2024 Aug 13, 2024	SELL	$18.21 - $24.5 $29,518 - $39,714	-1,621 Reduced 3.07%	51,189 $969,000
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $26,744 - $38,029	-1,434 Reduced 2.64%	52,810 $1.17 Million
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $19,918 - $25,811	-1,205 Reduced 2.17%	54,244 $1.15 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $46,645 - $58,980	-2,323 Reduced 4.02%	55,449 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $39,954 - $48,228	-1,613 Reduced 2.72%	57,772 $1.44 Million
Q1 2023 May 17, 2023	SELL	$25.95 - $36.95 $54,027 - $76,929	-2,082 Reduced 3.39%	59,385 $1.66 Million
Q4 2022 Feb 08, 2023	SELL	$24.79 - $30.86 $6,048 - $7,529	-244 Reduced 0.4%	61,467 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $79,104 - $104,229	3,213 Added 5.49%	61,711 $1.6 Million
Q2 2022 Aug 16, 2022	BUY	$19.74 - $29.01 $214,948 - $315,889	10,889 Added 22.87%	58,498 $1.6 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $426 - $666	16 Added 0.03%	47,609 $1.27 Million
Q4 2021 Feb 16, 2022	BUY	$33.67 - $43.44 $15,117 - $19,504	449 Added 0.95%	47,593 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $13,945 - $16,234	-455 Reduced 0.96%	47,144 $1.54 Million
Q2 2021 Aug 19, 2021	SELL	$34.33 - $44.68 $34 - $44	-1 Reduced -0.0%	47,599 $1.64 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $1,754 - $2,316	43 Added 0.09%	47,600 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $3,369 - $4,381	92 Added 0.19%	47,557 $2.08 Million
Q3 2020 Nov 10, 2020	BUY	$30.09 - $43.02 $179,155 - $256,141	5,954 Added 14.34%	47,465 $1.84 Million
Q2 2020 Aug 12, 2020	BUY	$27.76 - $33.42 $4,275 - $5,146	154 Added 0.37%	41,511 $1.35 Million
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $42,704 - $77,998	2,064 Added 5.25%	41,357 $1.24 Million
Q4 2019 Feb 13, 2020	BUY	$32.75 - $41.43 $5,043 - $6,380	154 Added 0.39%	39,293 $1.35 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $1.32 Million - $1.81 Million	39,139 New	39,139 $1.32 Million

Others Institutions Holding XNCR

# of Institutions

200

Shares Held

73.7M

Call Options Held

1.7K

Put Options Held

4.2K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $967M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Xencor Inc Transaction History